Davide Campari‑Milano saw its shares tumble 11% in early European trading after the Aperol producer posted first‑quarter revenue of 643 million euros, missing the 651.1 million‑euro forecast compiled by Visible Alpha. The disappointment erased most of the 5% gain the stock has delivered so far in 2024, prompting a swift sell‑off.

Organic sales climbed 2.9% year‑on‑year, well under the 5.1% rise Jefferies analysts had penciled in. Though Campari is recovering faster than many European spirits firms still wrestling with a post‑pandemic slump, the firm’s pace remains modest, suggesting overall sector’s broader revival is still tentative.

The 11% drop translates into a valuation correction that wipes out a sizable portion of the modest upside built into Campari’s price this year. Analysts note that the miss signals lingering demand weakness, forcing investors to reassess the durability of the company’s recovery narrative and its near‑term earnings outlook.

Going forward, market attention will zero in on Campari’s ability to accelerate organic growth in the second quarter. A stronger performance could restore confidence, while another miss may deepen the correction and pressure the stock further. The coming results will be the litmus test for the brand’s rebound.